期刊
HUMAN MUTATION
卷 32, 期 2, 页码 213-219出版社
WILEY
DOI: 10.1002/humu.21418
关键词
neurofibromatosis type 1; NF1; microdeletion; recombination hotspots; mosaicism
资金
- Deutsche Forschungsgemeinschaft [KE 724/9-1, KE 724/7-1]
- Deutsche Krebshilfe [108793]
- Spanish Health Research Fund
- Carlos III Health Institute
- Catalan Health Institute and Autonomous Government of Catalonia
- Asociacion Espanola de Afectados de Neurofibromatosis
- Asociacion Espanola contra el Cancer [ISCIIIRETIC, RD06/0020/1051, RD06/0020/1050, PI081871, 2009SGR290]
- International Graduate School in Molecular Medicine, Ulm
Mosaicism is an important feature of type-1 neurofibromatosis (NF1) on account of its impact upon both clinical manifestations and transmission risk. Using FISH and MLPA to screen 3500 NF1 patients, we identified 146 individuals harboring gross NF1 deletions, 14 of whom (9.6%) displayed somatic mosaicism. The high rate of mosaicism in patients with NF1 deletions supports the postulated idea of a direct relationship between the high new mutation rate in this cancer predisposition syndrome and the frequency of mosaicism. Seven of the 14 mosaic NF1 deletions were type-2, whereas four were putatively type-1, and three were atypical. Two of the four probable type-1 deletions were confirmed as such by breakpoint-spanning PCR or SNP analysis. Both deletions were associated with a generalized manifestation of NF1. Independently, we identified a third patient with a mosaic type-1 NF1 deletion who exhibited segmental NF1. Together, these three cases constitute the first proven mosaic type-1 deletions so far reported. In two of these three mosaic type-1 deletions, the breakpoints were located within PRS1 and PRS2, previously identified as hotspots for nonallelic homologous recombination (NAHR) during meiosis. Hence, NAHR within PRS1 and PRS2 is not confined to meiosis but may also occur during postzygotic mitotic cell cycles. Hum Mutat 32:213-219, 2011. (C) 2011 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据